Funding for this research was provided by:
Alzheimer's Association (DNCFI-12-241602)
Translational Science Institute, Wake Forest School of Medicine
National Center for Advancing Translational Sciences (UL1TR001420)
National Institute on Aging (P30AG21332)
Received: 31 January 2017
Accepted: 20 November 2017
First Online: 6 December 2017
Ethics approval and consent to participate
: The Wake Forest School of Medicine Institutional Review Board approved both the phase 1 pilot study and the phase 2 validation study, and all subjects provided signed informed consent. The IRB number for SIMBAC is IRB00006974.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.